Comparison of Ultrastructural Features Between Patients with Mercury-associated Membranous Nephropathy and Idiopathic Membranous Nephropathy

Background: Prolonged exposure to mercury can cause membranous nephropathy. Mercury-associated membranous nephropathy (M-MN) and idiopathic membranous nephropathy (I-MN) have similar clinical manifestations, making misdiagnoses likely. We compared the clinicopathological and ultrastructural features of M-MN and I-MN. Methods: We retrospectively analyzed the clinicopathological data of 13 M-MN patients and 13 I-MN patients. Electron micrographs of glomerular capillaries were taken, and foot process width (FPW) and the number of foot processes per 10 mm glomerular basement membrane (GBM) were calculated. The presence and location of electron-dense deposits were recorded. Results: Compared with I-MN patients, M-MN patients were younger (38.7 +/- 8.5 versus 45.8 +/- 5.7 years, P = 0.020), achieved complete remission more quickly (9.0 +/- 6.1 versus 20.3 +/- 9.8 months, P = 0.004), and had a lower relapse rate (0 versus 45.5%, P = 0.014). Patients with M-MN also had lower FPW (974.3 [interquartile range or IQR, 791.2-1504.4] nm versus 2370.6 [IQR, 2219.4-2559.1] nm, P = 0.001), more foot processes per 10mm GBM (8.1 [IQR, 5.2-10.0] versus 3.3 [IQR, 3.1-3.5], P = 0.001), and a higher rate of mesangial electron-dense deposits (41.7% versus 0, P = 0.015). A cut-off FPW of <1654 nm differentiated M-MN from I-MN with high sensitivity (92.3%) and specificity (83.3%). Conclusions: Foot process effacement was less severe in M-MN than in I-MN. In patients with mercury toxic exposure, MN with less severe foot processes effacement suggested mercury could be the cause. Better prognosis in patients with M-MN may be associated with minor podocyte damage.

Automated summary

This study compared the clinicopathological and ultrastructural features of patients with mercury-associated membranous nephropathy (M-MN) and idiopathic membranous nephropathy (I-MN). The results showed that M-MN patients were younger, achieved complete remission more quickly, and had a lower relapse rate compared to I-MN patients. M-MN patients also exhibited less severe foot process effacement and a higher rate of mesangial electron-dense deposits.